Knight Adds New Dimension to 3D Signatures Partnership
MONTREAL, QUEBEC--(Marketwired - Dec 19, 2016) - Knight Therapeutics Inc. ("Knight") (TSX:GUD), a leading Canadian specialty pharmaceutical company, announced today that it invested $180,000 in 3D Signatures Inc. (TSX VENTURE:DXD) ("3DS…